it’s what we do
Viatris Inc., is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind GLOBAL HEALTHCARE GATEWAY®.
Formed in November 2020, through the combination of Mylan and Pfizer's Upjohn business, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products.
Viatris AdvocateTM Patient Support Programs
Viatris believes in extending support services to patients at every stage of their journey regardless of their reimbursement profile. Viatris AdvocateTM programs are in place to help healthcare providers and patients navigate their personal reimbursement landscape, provide financial assistance when needed, and a suite of other services tailored to the product the patient has been prescribed.